← Back to Screener
eXoZymes Inc. Common Stock (EXOZ)
Price$9.67
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-49.95%
Price vs S&P 500 (4W)-4.00%
VGM Score47.97
Market Capitalization$83.48M
All Metrics
Book Value / Share (Quarterly)$0.18
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.84
Price vs S&P 500 (YTD)-19.03%
EPS (TTM)$-1.15
10-Day Avg Trading Volume0.00M
EPS Excl Extra (TTM)$-1.15
EPS (Annual)$-1.09
ROI (Annual)-261.23%
Cash / Share (Quarterly)$0.17
ROA (Last FY)-153.37%
EBITD / Share (TTM)$-1.17
Cash Flow / Share (Annual)$-0.79
P/B Ratio54.63x
P/B Ratio (Quarterly)41.67x
Net Income / Employee (Annual)$-286,200
ROA (TTM)-141.28%
EPS Incl Extra (Annual)$-1.09
Current Ratio (Annual)2.51x
Quick Ratio (Quarterly)1.10x
3-Month Avg Trading Volume0.00M
Revenue / Employee (TTM)$0
52-Week High$18.40
EPS Excl Extra (Annual)$-1.09
26-Week Price Return-34.01%
Quick Ratio (Annual)2.27x
13-Week Price Return9.39%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)1.32x
Enterprise Value$82.13M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.36
3-Month Return Std Dev62.58%
Net Income / Employee (TTM)$-302,300
ROE (Last FY)-269.59%
EPS Basic Excl Extra (Annual)$-1.09
Total Debt / Equity (Quarterly)0.06x
EPS Incl Extra (TTM)$-1.15
ROI (TTM)-215.05%
Revenue / Share (Annual)$0.00
Year-to-Date Return-9.68%
5-Day Price Return-0.76%
EPS Normalized (Annual)$-1.09
ROA (5Y Avg)-71.83%
Month-to-Date Return-1.35%
EBITD / Share (Annual)$-1.12
EPS Basic Excl Extra (TTM)$-1.15
P/B Ratio (Annual)26.91x
Book Value / Share (Annual)$0.40
Price vs S&P 500 (13W)-0.36%
Beta1.33x
Revenue / Share (TTM)$0.00
ROE (TTM)-220.64%
52-Week Low$7.08
mGradeC
vgmGradeC
Show chart for
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
EXOZeXoZymes Inc. Common Stock | — | — | C | $9.67 |
| AMGNAmgen Inc | C | C | C | $329.13 |
| GILDGilead Sciences Inc | C | B | C | $131.10 |
| ARGXargenx SE American Depositary Shares | D | A | C | $836.09 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $163.68 |
| BIIBBiogen Inc. Common Stock | B | D | B | $192.23 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.70 |
| MRNAModerna, Inc. Common Stock | C | B | B | $46.06 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $161.00 |
| EXELExelixis Inc | C | B | B | $50.28 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | B | $298.10 |
About
EXoZymes develops a biomanufacturing platform for sustainable production of high-value biochemicals, including active pharmaceutical ingredients, biofuels, food flavors, and cosmetics. The company's platform offers a cost-effective alternative to traditional chemical synthesis across multiple end markets.